Literature DB >> 2578830

Anticomplementary activity of dextran derivatives.

M Mauzac, F Maillet, J Jozefonvicz, M D Kazatchkine.   

Abstract

Substitution with carboxylic and benzylamine sulphonated groups conferred on dextran both antithrombic activity and the capacity to inhibit formation of the amplification C3 convertase of complement. In dextrans substituted with carboxylic groups (greater than 40%), a high content of sulphonate (greater than 10%) resulted in both anticomplementary and antithrombic properties whereas a lower content of sulphonate resulted in high anticomplementary but weak antithrombic activity. The anticomplementary activity of highly substituted dextrans was similar to that of heparin, although anticoagulant activity was much lower than in heparin, confirming independent structural requirements for both activities in the heparin molecule.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578830     DOI: 10.1016/0142-9612(85)90040-7

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  4 in total

1.  In vitro stimulation of human endothelial cells by derivatized dextrans.

Authors:  D Letourneur; J Champion; F Slaoui; J Jozefonvicz
Journal:  In Vitro Cell Dev Biol       Date:  1993-01

2.  Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups.

Authors:  Carolina Salvador-Morales; Liangfang Zhang; Robert Langer; Omid C Farokhzad
Journal:  Biomaterials       Date:  2009-01-23       Impact factor: 12.479

3.  Structural analysis and anti-complement activity of polysaccharides from Kjellmaniella crsaaifolia.

Authors:  Wenjing Zhang; Weihua Jin; Delin Sun; Luyu Zhao; Jing Wang; Delin Duan; Quanbin Zhang
Journal:  Mar Drugs       Date:  2015-03-16       Impact factor: 5.118

4.  The Structure-Activity Relationship between Marine Algae Polysaccharides and Anti-Complement Activity.

Authors:  Weihua Jin; Wenjing Zhang; Hongze Liang; Quanbin Zhang
Journal:  Mar Drugs       Date:  2015-12-25       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.